The physiological control of cellular proliferation and differentiation is an integrated regulatory process. This conclusion is based upon observations using numerous in vivo and in vitro experimental systems of which murine BALB/c 3T3 T mesenchymal stem cells represent an excellent in vitro model. In these cells the coupling of growth arrest and differentiation occurs at a distinct biological state, and this predifferentiation arrest state is distinguishable by a variety of criteria from other restriction points, such as the growth factor deficiency arrest state and the nutrient deficiency arrest state. Most importantly, only cells at this predifferentiation arrest state acquire the potential to differentiate without undergoing DNA synthesis. From this state, differentiation can then occur as a two-step process. Cells first undergo nonterminal differentiation and, second, they terminally differentiate. Nonterminal differentiation is characterized by expression of a completely differentiated adipocyte phenotype with retention of proliferative potential. Thereafter, when nonterminally differentiated cells undergo the terminal event in differentiation, they irreversibly lose their prolifertive potential. In this paper, data are reviewed which establish that the integrated control of proliferation and differentiation in 3T3 T mesenchymal stem cells is mediated both at the predifferentiation arrest state and at the state of nonterminal differentiation.
Introduction
To establish the mechanisms that regulate the integrated control of proliferation and differentiation, mu- rine BALB/c 3T3 T mesenchymal stem cells have been used as a model in vitro system. This stem cell line is valuable for a variety of reasons. In contrast to most other cell differentiation systems, such as the erythroleukemia, neuroblastoma, melanoma, and embryonal carcinoma cells that are transformed (1) (2) (3) (4) , 3T3 T stem cells are nontransformed with respect to the two-stage model of carcinogenesis (5, 6) . They therefore can be used for studies on the mechanisms of the initiation and promotion of carcinogenesis (6) (7) (8) (9) (10) (11) . This is true even though they are immortal and aneuploid. Another valuable characteristic of 3T3 T stem cells is that they possess the ability to differ-*Section of Experimental Pathology, Mayo Clinic/Foundation, Rochester, MN 55905. entiate and therein to integrally regulate the control ot proliferation and differentiation under defined physiological conditions. Somewhat similar biological characteristics have also recently been reported in normal diploid human keratinocyte progenitor cells (12) (13) (14) (15) . 3T3 T mesenchymal stem cells are thought to be representative of a variety of related cell lines including the 3T3-L1 (16) , 3T3-F442A (17) , 3T3-C2 (18) , obl7 (19) , and (10T1/2)TAl (20) . When undifferentiated, all such cells have a fibroblastlike morphology, but when they differentiate into specific cell types, such as adipocytes, they modulate not only their morphology but also their function. In this regard, adipocytes were previously considered to be terminally differentiated and therefore incapable of proliferation and cell division. It has, however, now been established that adipocytes as well as some other differentiated tissues can reproduce and undergo differentiation and maturation (5) (6) (7) (8) (9) (10) (11) 21, 22) . The general phenomena of cell differentiation and the cellular and molecular changes that occur during this process have been elucidated in studies involving these excellent experimental systems and in studies on differentiation into a variety of mesen-chymal cell types, including adipocytes, striated muscle cells, chondrocytes, vascular pericytes, and macrophages (5, 23, 24) .
In this paper the observations that have been made concerning the differentiation of 3T3 T stem cells into adipocytes will be reviewed, especially the processes involved in the integrated regulation of proliferation and differentiation. The basis for these studies was the development of experimental methods to induce rapid and parasynchronous differentiation of these cells into adipocytes at low density under physiological conditions rather than as in other experimental systems In this regard, studies were performed to determine if neoplastic transformation is associated with development of a selective defect in one or more of the G, growth arrest processes (33) . Upon examining eight clones and several uncloned tumorigenic 3T3 T stem cell lines, it was initially shown that all the tumorigenic cell lines lacked the ability to undergo predifferentiation growth arrest and to differentiate, whereas some transformed cells did retain the ability to growth arrest at low density when deprived of growth factors and/or nutrients. More detailed recent studies, however, have established that some transformed 3T3 T stem cells can in fact differentiate even though they do express significant defects in the stringency of their differentiation regulatory mechanisms (8) . In fact, it has been concluded that carcinogenesis is probably associated with the development of defects in the stringency by which proliferation and differentiation are integrally regulated. The characteristics of these defects are also thought to determine whether a cancer is well differentiated and slow growing or poorly differentiated and rapidly growing. A variety of additional studies have been performed comparing cells arrested at the GD, GS, and GN states (see Fig. 1 for a definition of these terns). These studies all substantiate the conclusion that GD arrested cells are distinct by a variety of criteria, including the expression of specific biochemical and morphological markers (Fig. 2) . For example, when scanning electron microscopy was employed to examine the cell surface characteristics of 3T3 T stem cells at various states in the G1 phase of the cell cycle, predifferentiation growth arrested cells demonstrated distinct long cell surface microvilli, which were not observed in GS or GN arrested cells (34) .
GD, GS, and GN arrest states were also distinguished in their topography in G1. Kinetic studies were performed to measure the time required for cells arrested at various G1 states to initiate synthesis of DNA and to determine the ability of these growth arrested cells to convert from one arrest state to another in the absence of DNA synthesis. Relative to the start of the G1 phase of the cell cycle, a topographical sequence was established in the following order: GD, GS, GN (35 (45) , melanoma cells (46) , erythroleukemia cells exposed to hemin (1) , and neuroblastoma cells exposed to butyrate (47) . Nonetheless, the process of nonterminal differentiation has not been studied in detail nor has the terminal event in differentiation. 3T3 T stem cells were therefore evaluated in this regard.
Experimental conditions were developed that limited the terminal phase of differentiation in 3T3 T adipocytes and thereby enrich cultures in nonterminally differentiated cells. The culture of low density 3T3 T stem cells in heparinized DME containing a plasma fraction, designated citrate eluate of the barium-precipitated plasma (CEPH), achieved this result (48, 49) . Such cultures first underwent predifferentiation growth arrest, and flow microfluorometric analysis showed these cells to have the following cell cycle distribution: G1, 87%; S, 3%; G2/M, 10%. Thereafter, these cultures differentiated into adipocytes that retained their proliferative potential for extended intervals and therefore exist in a nonterminally differentiated state. Proof of this was documented by the demonstration that 80 to 90% of such adipocytes were capable of undergoing DNA synthesis and clonal proliferation (Fig. 3 ). In the 3T3 T mesenchymal stem cell system, expression of the differentiated phenotype and loss of proliferative potential are therefore separately controlled processes; the expression of the differentiated phenotype is not sufficient to induce loss of proliferative potential.
The development of experimental conditions to induce and purify adipocytes at the nonterminal states of differentiation is a significant one (48) . While the previous in vivo and in vitro studies mentioned above provided evidence for the existence of a nonterminally differentiated state and the transition of such cells to a subsequent terminal state of differentiation, with the 3T3 T stem ceJl system it has been possible to actually perform well-controlled studies on the transition from nonterminal to terminal states of differentiation. Thus, this model provides an excellent system to examine the separate and specific control processes associated with differentiation per se and those processes associated with loss of proliferative potential. These will be discussed in the next section of this review.
Numerous biochemical changes are associated with the induction of adipocyte differentiation. These include an increase in the glucose uptake and a significant increase in the concentration of enzymes involved in lipogenesis. These enzymes include lipoprotein lipase, fatty acid synthetase, diacylglycerolacyltransferase, phosphatidic acid phosphase, glycerol-3-phosphate dehydrogenase (G3PD), and acetyl COA carboxylase (16) (17) (18) (19) (20) (21) . In the 3T3 T cell system, the specific expression of the nonterminal adipocyte phenotype has also been shown to be associated with the accumulation of intracellular lipid droplets and increased activity of G3PD and lipoprotein lipase (49) . In fact, there is a very good correlation in the kinetics of nonterminal differentiation using assays for the activity of lipoprotein lipase, glycerol-3-phosphate dehydrogenase, and presumably all other lipogenic enzymes and morphological assays.
The process of nonterminal differentiation can be induced by a variety of factors including proteins in blood and various hormones. In addition, it can be modulated by TGF-P (50) . That is, while other biologically active polypeptides, such as EGF, NGF, and somatomedin C, have no specific effect on 3T3 T adipocyte differentiation even at high concentrations, TGF-P is a potent reversible inhibitor of adipocyte differentiation (50% inhibition at 0.06-0.08 ng/mL). TGF-f actually inhibits differentiation in a cell cycle-dependent manner by its effect on a specific phase of the differentiation process. That is, TGF-p blocks the transition from the predifferentiation growth arrest state to the nonterminal differentiation state.
During the process of nonterminal differentiation, cells not only acquire a completely differentiated phenotype but they also downregulate their response to growth factors. This phenomena does not prevent the nonterminally differentiated cells from proliferating; it simply requires that they be exposed to a high concentration of appropriate mitogens. For example, whereas predifferentiation growth arrested cells can be induced to proliferate with 5% fetal calf serum (FCS), nonterminally differentiated adipocytes require 30% FCS plus 50 ,Ag/mL insulin to express a maximum mitogenic response. The integrated control of cell proliferation and differentiation is therefore mediated not only at the predifferentiation growth arrest state but also at the nonterminal differentiation state.
This finding answers a question that previously has confounded investigators studying the control of cell differentiation. Do cells have to undergo a process designated commitment prior to terminal differentiation? With respect to the 3T3 T model stem cell system, it appears that there is no specific commitment step occurring that makes cells differentiate terminally because neither reversible arrest at the predifferentiation state nor nonterminal differentiation predisposes cells subsequently to undergo the terminal event in differentiation and thereby lose their proliferative potential (24) . Previous theories proposing that loss of proliferative potential results from an inhibitory effect of differentiation gene products on DNA synthesis, on cellular proliferation, and/or on cell division therefore cannot hold true in these cells because a stable, nonterminally differentiated state clearly exists and it can be experimentally maintained and modulated.
Ib reiterate, the characteristics of adipocytes at the nonterminal state of differentiation include: a) the potential to make decisions to integrate the control of differentiation and proliferation; b) the expression of a fully differentiated phenotype; c) the retention of proliferative potential; and d) the expression of decreased responsiveness to growth factors. In addition, nonterminally differentiated adipocytes can be induced to dedifferentiate and subsequently redifferentiate into another cell type (23, 24) . That is, studies have specifically demonstrated that nonterminally differentiated adipocytes can be induced to lose the fat cell phenotype without undergoing DNA synthesis when treated with retinoic acid, 12-O-tetradecanoylphorbol-13-acetate (TPA), or methyl isobutyl xanthine (48) . Such cells that have lost the adipocyte phenotype yet remain in the G, phase of the cell cycle and retain most of the characteristics of cells in predifferentiation growth arrest thereafter become responsive to environmental influences that can further induce their redifferentiation into adipocytes without DNA synthesis or their prolifer- ation and/or differentiation into another cell type (24) . In summary, the studies reviewed demonstrate that following growth arrest at the predifferentiation state, two steps are involved in adipocyte differentiation. First, the growth arrested cells undergo nonterminal differentiation wherein they develop an adipocyte morphology yet retain their proliferative potential. Thereafter, terminal differentiation occurs wherein differentiated cells specifically lose their proliferative potential. Most important, these results establish that the integrated control of proliferation and differentiation can be mediated at the nonterminal state of differentiation.
Terminal Differentiation State
The control of cellular proliferation is an important regulatory process. In normal stem cells, it appears to be mediated by a balance of forces that either stimulate proliferation or stimulate nonterminal or terminal differentiation. Most previous experimental studies on the control of cellular proliferation have examined the mechanisms by which DNA synthesis and cellular proliferation are initiated in quiescent cell populations. In related studies, many growth factors and several growth inhibitory factors have been characterized and purified. Concerning the latter, these factors generally inhibit DNA synthesis and/or cell proliferation in a transient, reversible manner.
Few studies have attempted to establish the mechanisms by which a cell's proliferative potential can be irreversibly limited in nonterminally differentiated cell populations. The reason is because few, if any, adequate model cell systems have previously been developed wherein nonterminally differentiated cells can be rapidly and parasynchronously induced to terminally differentiate and irreversibly lose their proliferative potential when exposed to a physiological inducer. In this respect, the 3T3 T stem cell system provides an excellent model with which to study the terminal event in cellular differentiation. In this cell system, distinct nonterminal and terminal states of differentiation can be identified, and transition from the nonterminal to the terminal states of differentiation can be induced by a component of human plasma (48, 49) .
What are the characteristics of the terminal event in cellular differentiation and how do nonterminal and terminal cells differ? A series of biological, biochemical, and molecular studies have been performed to define as carefully as possible the answer to these questions and to establish the mechanisms that mediate the irreversible loss of the proliferative potential.
Nonterminally and terminally differentiated populations of 3T3 T adipocytes exhibit an essentially identical morphology, they express similar levels of adipogenic enzymes, and they are similarly growth arrested in the GI phase of the cell cycle (Fig. 3) . A reasonable assumption therefore is that they differ only in their proliferative capacity. Since such cells are very similar, studies were performed to determine if any protein differences between these cells could be observed and whether these differences might be associated with loss of proliferative potential associated with the terminal event in differentiation. By analysis of silver-stained two-dimensional gel electrophoretograms, a very limited number of differences in the composition of major proteins between nonterminally and terminally differentiated adipocytes were indeed detected. Out of more than 1000 protein spots evaluated, only 6 were selectively expressed in terminally differentiated cells; of these, 2 were localized to the cytoplasm, and 4 were localized to the nucleus (51). Another distinct protein was selectively identified in the nucleus of nonterminally differentiated adipocytes.
More recently, three distinct basic nuclear proteins have been identified in nonterminally differentiated cells that are selectively lost during the process of terminal differentiation. These proteins were identified by the use of cross-reactive monoclonal antibodies to heat shock protein 90 (unpublished observations). Additional studies are currently in progress to further characterize the structure and function of these proteins as are experiments to clone and characterize their genes. In this regard, it is important to note that these observations indicate that the terminal event in the process of mesenchymal stem cell differentiation is probably associated with modulation in the expression of less than 1% of the major cytosolic and nuclear proteins.
The significance of these differences in the expression or abundance of specific proteins in nonterminally and terminally differentiated adipocytes is still an open question. The differences could be due to primary changes in gene expression at the two states of differentiation or to changes in the rate of protein synthesis/degradation. Variations in posttranslational protein modification such as glycosylation and/or acetylation might also account for some of the observed differences. Posttranslational protein modification via differential phosphorylation is, however, not likely to be involved in this process since significant differences were not observed in recent studies evaluating the phosphoproteins in nonterminally and terminally differentiated adipocytes (unpublished observations). The most significant question that must now be resolved concerns which specific proteins function to control cellular proliferation and how they can irreversibly cause cells to lose proliferative potential.
It is also important to establish which proteins in human plasma actually induce transition from the nonterminal to terminal state of differentiation. This goal has been partially achieved by the 20,000-fold purification of a component of human plasma that induces the terminal event in adipocyte differentiation (52) . This factor has an apparent molecular weight of 45,000 daltons and an isoelectric point of approximately 7.6 . It is trypsin sensitive, acid and heat labile, and is resistant to treatment with dithiothreitol and alkali. The ability of this human plasma protein to induce the irreversible loss of proliferative potential associated with the terminal event in adipocyte differentiation serves as the basis for its designation "aproliferin" (52) . In this regard, none of the more than 20 pharmacologic or physiologic agents that have been examined can mimic the biologic effect of aproliferin. Therefore, it appears that aproliferin is a functionally distinct protein that can convert nonterminal adipocytes to terminal adipocytes within 12 hr of exposure. The mechanism by which aproliferin mediates this effect is, however, still under investigation. Experiments are also in progress to prepare anti-aproliferin monoclonal antibodies, to sequence aproliferin, and to clone the gene for this potentially important protein.
Additional studies have furthermore established that the terminal event in differentiation also can be reversibly inhibited by tumor necrosis factor (TNF). That is, whereas TGF-P selectively inhibits the transition from predifferentiation growth arrest to nonterminal differentiation, TNF selectively inhibits the transition from nonterminal differentiation to terminal differentiation (unpublished observations). Evidence has also been obtained that suggests that aberrant 3T3 T stem cell clones that cannot terminally differentiate actually secrete molecules that function in a manner similar to TNF to block their own terminal differentiation in an autocrine and/or paracrine manner.
Tb summarize, adipocytes that undergo the terminal event in differentiation are characterized by two most important features. They cannot reinitiate proliferation nor can they be induced to lose their adipocyte phenotype. During terminal differentiation, adipocytes appear to acquire six distinct polypeptides not present in nonterminally differentiated cells and to lose at least four proteins that are present in nonterminally differentiated adipocytes. It also appears that these changes are induced by exposure of cells to aproliferin. By definition, terminally differentiated cells therefore do not mediate any aspect of the integrated control of proliferation and differentiation because they cannot modify their differentiation nor proliferation even though they are viable cells.
Resume and Speculation Figure 1 again summarizes the results of our studies that establish the biological processes by which 3T3 T mesenchymal stem cells integrally regulate control of their proliferation and differentiation. The data show that in these stem cells multiple cell cycle restriction points exist but that the integrated control of proliferation and differentiation is mediated only at a distinct predifferentiation growth arrest state and at the state of nonterminal differentiation. The results also define the characteristics of these states and the fact that nonterminally differentiated cells can be specifically induced to undergo the terminal event in differentiation following exposure to the human plasma protein designated aproliferin.
A series of additional questions now need to be resolved specifically concerning whether all multipotential stem cells demonstrate regulatory mechanisms comparable to 3T3 T mesenchymal stem cells and/or whether progenitor cells show a different regulatory mechanism. Although our model for the integrated control of proliferation and differentiation in 3T3 T stem cells has been confirmed in studies on neural cells (53) , myogenic cells (54) , and embryonal carcinoma cells (4), we speculate that some cell types may have evolved somewhat distinct regulatory mechanisms. We also speculate that progenitor cells that have a more restricted differentiation and/or proliferation potential may in fact be found to integrally regulate proliferation and differentiation in a distinct manner.
The challenge for the future is to clearly define the options cells have to control their proliferation and differentiation and to determine what specific defects in these regulatory mechanisms occur during carcinogenesis and other disease processes.
